SHINE Medical Technologies To Site New Manufacturing Plant In Janesville | Business

SHINE Medical Technologies, a Middleton-based company that creates cancer treatment elements announced that it intends to build a new manufacturing plant in Janesville. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth, company officials said.

They said the new plant will enable SHINE to become the first large-scale domestic supplier of molybdenum-99 (moly-99), a medical isotope that is used in more than 30 different diagnostic imaging procedures. Each day in the United States alone, more than 50,000 diagnostic nuclear medicine procedures take place that rely on moly-99, creating a $500 million annual world-wide market, officials said.

"The medically important isotope, moly-99, is crucial to the successful diagnosis of cancer and heart disease throughout the world," said Dr. Richard Steeves, M.D., Ph.D., professor emeritus of human oncology at the University of Wisconsin-Madison, in a news release. "With moly-99, physicians can determine the extent to which heart disease or cancer has spread, information which is critical to successful treatment."

SHINE invites the Janesville community to learn about its plans at an open house at the Janesville Rotary Botanical Gardens 5 to 7 p.m. on Tuesday, Feb. 7.